Eli Lilly (LLY) Net Margin (2009 - 2026)
Eli Lilly's Net Margin came in at 26.44% for Q3 2026, down 5.28 percentage points from 31.72% a year earlier and down 4.44 percentage points from the prior quarter.
Eli Lilly (LLY) Net Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Eli Lilly reported Net Margin of 31.90%, up 0.91 percentage points year-over-year; for FY2025, it came in at 31.67%, up 8.16 percentage points from FY2024.
- Net Margin carries a five-year change of +6.43 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was 23.51% in FY2024 (+8.16 pp), 15.36% in FY2023 (-6.52 pp), 21.88% in FY2022 (+2.17 pp) and 19.71% in FY2021 (-5.53 pp).
- The Q3 2026 figure represents the lowest quarterly Net Margin since Q1 2025.
- Year-over-year, Net Margin increased in five of the last eight quarters, with an average year-over-year change of +5.67 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q3 2025 (a gain of 23.24 percentage points), and the weakest in Q3 2023 (a drop of 21.52 percentage points).
- Business Quant data shows LLY's Net Margin at 30.88% (Q2 2026), 37.36% (Q1 2026) and 34.41% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 19.00% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.44% |
| Jun 30, 2026 | 30.88% |
| Mar 31, 2026 | 37.36% |
| Dec 31, 2025 | 34.41% |
| Sep 30, 2025 | 31.72% |
| Jun 30, 2025 | 36.39% |
| Mar 31, 2025 | 21.67% |
| Dec 31, 2024 | 32.59% |
| Sep 30, 2024 | 8.48% |
| Jun 30, 2024 | 26.25% |
| Mar 31, 2024 | 25.58% |
| Dec 31, 2023 | 23.41% |
| Sep 30, 2023 | -0.60% |
| Jun 30, 2023 | 21.21% |
| Mar 31, 2023 | 19.32% |
| Dec 31, 2022 | 26.54% |
| Sep 30, 2022 | 20.91% |
| Jun 30, 2022 | 14.68% |
| Mar 31, 2022 | 24.36% |
| Dec 31, 2021 | 21.58% |
Eli Lilly Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=LLY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();